Published in Blood Weekly, January 8th, 2009
"The aim of our study was to assess microvascular damage reduction with quantitative myocardial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.